EC
CRL icon

Eminence Capital’s Charles River Laboratories CRL Stock Holding History

Eminence Capital’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-435,454
Closed -$65.5M – 51
2025
Q1 		$65.5M Sell
435,454
-192,018
-31% -$32.2M 1.1% 37
2024
Q4 		$116M Sell
627,472
-376,000
-37% -$72.4M 1.77% 29
2024
Q3 		$198M Buy
+1,003,472
New +$209M 3% 11
2021
Q1 		– Sell
-67,994
Closed -$17M – 74
2020
Q4 		$17M Buy
+67,994
New +$16.2M 0.19% 73
2020
Q3 		– Sell
-126,539
Closed -$22.1M – 80
2020
Q2 		$22.1M Buy
+126,539
New +$20.2M 0.29% 69

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $12B AUM 34.44% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $74.9B AUM 11.27% 1-Year Est. Return